Codes / ICD10CM / F16.220

F16.220 Hallucinogen dependence with intoxication, uncomplicated

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Hallucinogen Dependence with Intoxication, Uncomplicated
  • Medical Term: ICD-10-CM F16.220

Summary

Hallucinogen dependence with intoxication, uncomplicated, is a medical condition characterized by a persistent pattern of hallucinogen use leading to clinically significant impairment or distress, combined with the presence of intoxication. It involves a compulsive need to use substances like LSD, psilocybin, or mescaline, despite negative consequences, and includes tolerance, withdrawal symptoms, and an inability to control use. Intoxication may manifest as perceptual disturbances, mood changes, or impaired judgment during active use, without additional complicating factors.

Causes

Hallucinogen dependence typically develops from repeated or prolonged use of hallucinogenic substances. Psychological factors, such as pre-existing mental health conditions, and environmental influences, like social or peer pressure, may contribute to its onset. The drugs' mind-altering effects can reinforce continued use, while intoxication occurs when the substance is actively affecting the central nervous system.

Risk Factors

  • History of substance use disorders
  • Pre-existing mental health conditions
  • Young age, particularly adolescence or young adulthood
  • Access to hallucinogenic substances
  • Social or peer groups that normalize drug use

Symptoms

  • Persistent craving for hallucinogens
  • Inability to reduce or control use despite negative effects
  • Tolerance, requiring increased amounts for the same effect
  • Withdrawal symptoms when use is reduced or stopped
  • Neglect of personal or professional responsibilities due to use
  • Perceptual disturbances (e.g., hallucinations, distorted sensory experiences)
  • Mood changes (e.g., euphoria, anxiety, paranoia)
  • Impaired judgment or cognitive function during active use

Diagnosis

Diagnosis is based on a clinical evaluation of the patient's history, including patterns of substance use, and the presence of intoxication symptoms. Healthcare providers assess for a persistent pattern of use leading to impairment, along with physical or psychological signs of intoxication. The diagnosis requires ruling out other conditions that may mimic symptoms, such as other substance use disorders or mental health disorders.

Treatment Options

Treatment may include behavioral therapies, such as cognitive-behavioral therapy, to address dependence and modify use patterns. Supportive care for intoxication symptoms, such as monitoring and managing acute effects, is often necessary. Long-term management may involve counseling, support groups, or medication-assisted treatment if withdrawal symptoms are severe. Individualized plans are tailored to the patient's needs and history.

Prognosis and Follow-Up

Prognosis varies depending on the severity of dependence, co-occurring conditions, and adherence to treatment. Regular follow-up is essential to monitor progress, address relapse risks, and adjust treatment as needed. Early intervention and sustained support improve outcomes, though relapse is common without ongoing care.

Complications

  • Worsening of mental health conditions (e.g., anxiety, depression)
  • Impaired judgment leading to accidents or risky behaviors
  • Social or occupational dysfunction
  • Potential for polysubstance use or dependence
  • Long-term cognitive or perceptual changes with repeated use

Lifestyle & Prevention

  • Avoiding hallucinogenic substances is the primary prevention strategy.
  • Building healthy coping mechanisms for stress or mental health challenges.
  • Engaging in supportive social networks or therapy to reduce reliance on substances.
  • Educating oneself about the risks of hallucinogen use, especially in high-risk environments.

When to Seek Professional Help

Seek help if you or someone you know experiences persistent cravings, loss of control over use, or negative consequences from hallucinogen use. Intoxication symptoms that impair safety or daily functioning, or withdrawal symptoms when stopping use, also warrant immediate medical attention.

Tips for Medical Coders

Document the presence of hallucinogen dependence and active intoxication, including specific symptoms or behaviors observed. Ensure the uncomplicated nature of the condition is clearly noted, with no additional complicating factors (e.g., polysubstance use, severe withdrawal, or co-occurring disorders) to justify the F16.220 code. Clinical documentation should reflect the persistent pattern of use, impairment, and active intoxication to support accurate coding.

Book a walkthrough

F16.220 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.